GlassScriptPhysician profile
Maria Mazzotti
NPI 1689601288
$6,711.92
in general payments reported to CMS, 2019-2025
48 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $205 · 2021: $1,005 · 2022: $516 · 2023: $1,367 · 2024: $1,396 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,420.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,907.04 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $638.48 | 2019-2025 | Trintellix |
| Supernus Pharmaceuticals, INC. | $544.56 | 2021-2024 | Qelbree |
| Pfizer INC. | $498.76 | 2023-2025 | |
| Astellas Pharma US INC | $452.34 | 2019-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $210.44 | 2019-2025 | Airsupra, Breztri |
| Allergan, INC. | $180.17 | 2019-2020 | |
| Lilly USA, LLC | $172.44 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Hologic Sales and Service, LLC | $158.83 | 2019-2025 | Aptima |
| Idorsia Pharmaceuticals US INC | $146.60 | 2022-2025 | Quviviq, Quviviq |
| Glaxosmithkline, LLC. | $141.67 | 2019-2025 | Shingrix, Arexvy |
| Axsome Therapeutics, INC. | $131.19 | 2023-2025 | Auvelity |
| Novo Nordisk INC | $124.20 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $124.16 | 2023-2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $108.37 | 2022-2024 | Phexxi |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Mazzotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.